0000000001195364

AUTHOR

Adolfo Francesco Attili

0000-0001-7240-7246

showing 4 related works from this author

Intermediate and advanced hepatocellular carcinoma management in four Italian centers: patterns of treatment and costs

2015

Oncologymedicine.medical_specialtyOncologybusiness.industryHepatocellular carcinomaInternal medicinemedicineHematologymedicine.diseasebusinessAnnals of Oncology
researchProduct

Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers

2015

Giorgio Lorenzo Colombo,1 Calogero Cammà,2 Adolfo Francesco Attili,3 Roberto Ganga,4 Giovanni Battista Gaeta,5 Giuseppina Brancaccio,5 Jean Marie Franzini,6 Marco Volpe,6 Giuseppe Turchetti7 1Department of Drug Sciences, University of Pavia, Pavia, Italy; 2Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, Palermo, Italy; 3Department of Clinical Medicine, University of Rome (La Sapienza) Rome, Italy; 4Clinical Medicine Division, Ospedale Brotzu, Cagliari, Italy; 5Viral Hepatitis Unit, Second University, Naples, Italy; 6Business Integration Partners S.p.A., Milan, Italy; 7Scuola Superiore Sant’Anna, Pisa, Italy Background: Hepatocellular carcinoma (HCC) is…

Sorafenibmedicine.medical_specialtyTherapeutics and Clinical Risk ManagementTare weightTransarterial embolizationToxicology and Pharmaceutics (all)DiseaseDisease costDrugs costInternal medicinedisease costsHealth caremedicineDisease costs; Drugs cost; Sorafenib; Transarterial embolization; Medicine (all); Safety Research; Pharmacology Toxicology and Pharmaceutics (all); Chemical Health and Safety; Pharmacology (medical)Pharmacology (medical)General Pharmacology Toxicology and PharmaceuticsStage (cooking)Original ResearchPharmacologyChemical Health and Safetybusiness.industryDisease costs; drugs cost; sorafenib; transarterial embolizationMortality rateMedicine (all)General MedicineSorafenibmedicine.diseasedigestive system diseasesdisease costs drugs cost transarterial embolization sorafenibHepatocellular carcinomaPharmacology Toxicology and Pharmaceutics (all)businessLiver cancerSafety Researchmedicine.drug
researchProduct

Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costs.

2015

OncologyIntermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costsmedicine.medical_specialtyText miningIntermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costs.business.industryHealth PolicyHepatocellular carcinomaInternal medicinePublic Health Environmental and Occupational HealthMedicinebusinessmedicine.disease
researchProduct

Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

2018

Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Background and aims. A subclassification system for intermediate hepatocellular carcinoma (HCC) was recently proposed to optimize treatment allocation. The aim of this study was to assess the prognostic ability of that substaging proposal. Patients and methods This is a retrospective multicenter cohort study including patients with intermediate HCC treated with transarterial chemoembolization (TACE). Predictors of survival were identified using the Cox proportional regression model. Results 289 Barcelona Clinic Liver Cancer (BCLC) B patients were included. Medi…

MaleTime FactorsSpecialties of internal medicineKaplan-Meier EstimateGastroenterologyChemoembolization; Liver cancer; Radioembolization; Sorafenib; Staging system; Hepatology0302 clinical medicineRisk FactorsMedicineStage (cooking)Aged 80 and overLiver NeoplasmsGeneral MedicineMiddle AgedSorafenibTreatment OutcomeRC581-951Italy030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyFemaleChemoembolizationLiver cancerLiver cancerCohort studymedicine.drugSorafenibmedicine.medical_specialtyCarcinoma HepatocellularSettore MED/12 - GASTROENTEROLOGIARisk AssessmentDecision Support Techniques03 medical and health sciencesPredictive Value of TestsInternal medicineHumansChemoembolization TherapeuticRadioembolizationAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesHepatologybusiness.industryProportional hazards modelRetrospective cohort studymedicine.diseaseStaging systemLog-rank testMultivariate Analysisbusiness
researchProduct